Gene · 7079
Papers1,944
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,944
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blood Biomarkers for Triaging Patients for Suspected Stroke: Every Minute Counts. | J Clin Med | 2022 | 35888011 | PubTator, text mining | PubMed |
| MicroRNAs in Dystrophinopathy. | Int J Mol Sci | 2022 | 35887128 | PubTator, text mining | PubMed |
| The Mechanism and Role of ADAMTS Protein Family in Osteoarthritis. | Biomolecules | 2022 | 35883515 | PubTator, text mining | PubMed |
| An α2-Adrenergic Agonist, Brimonidine, Beneficially Affects the TGF-β2-Treated Cellular Properties in an In Vitro Culture Model. | Bioengineering (Basel) | 2022 | 35877361 | PubTator, text mining | PubMed |
| Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels. | Mult Scler | 2022 | 35848622 | PubTator, text mining | PubMed |
| Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCγ1 axis. | J Hypertens | 2022 | 35848503 | PubTator, text mining | PubMed |
| Colorectal Cancer Chemotherapy Drug Bevacizumab May Induce Muscle Atrophy Through CDKN1A and TIMP4. | Front Oncol | 2022 | 35847900 | PubTator, text mining | PubMed |
| Fibroblast morphology, growth rate and gene expression in facial melasma. | An Bras Dermatol | 2022 | 35840442 | PubTator, text mining | PubMed |
| 3D culturing of human pluripotent stem cells-derived endothelial cells for vascular regeneration. | Theranostics | 2022 | 35832092 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the E2F Transcription Factor Family in Human Lung Adenocarcinoma. | Int J Gen Med | 2022 | 35811776 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| Probiotic Lactobacillus rhamnosus GG (LGG) restrains the angiogenic potential of colorectal carcinoma cells by activating a proresolving program via formyl peptide receptor 1. | Mol Oncol | 2022 | 35808840 | PubTator, text mining | PubMed |
| Transcriptomic and Functional Evidence for Differential Effects of MCF-7 Breast Cancer Cell-Secretome on Vascular and Lymphatic Endothelial Cell Growth. | Int J Mol Sci | 2022 | 35806196 | PubTator, text mining | PubMed |
| Pituitary Tumor-Transforming Gene 1/Delta like Non-Canonical Notch Ligand 1 Signaling in Chronic Liver Diseases. | Int J Mol Sci | 2022 | 35805898 | PubTator, text mining | PubMed |
| Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play. | Int J Mol Sci | 2022 | 35805895 | PubTator, text mining | PubMed |
| Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis. | Cancers (Basel) | 2022 | 35805035 | PubTator, text mining | PubMed |
| Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment. | Brain Commun | 2022 | 35800899 | PubTator, text mining | PubMed |
| Development of a Risk Nomogram Model for Identifying Interstitial Lung Disease in Patients With Rheumatoid Arthritis. | Front Immunol | 2022 | 35784288 | PubTator, text mining | PubMed |
| Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside. | Front Immunol | 2022 | 35757736 | PubTator, text mining | PubMed |
| Microarray analysis of long non-coding RNAs related to osteogenic differentiation of human dental pulp stem cells. | J Dent Sci | 2022 | 35756759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7079/papers?page=17